JCR Pharmaceuticals Co.,Ltd. [4552.T]
TOKYO, Jun 23 (Pulse News Wire) – JCR Pharmaceuticals CO.,LTD. (4552.T) decided to repurchase its own shares as part of its restricted stock compensation program for executives.
The repurchase, scheduled for July 22, involves 216,000 ordinary shares at a price of ¥456 per share, totaling ¥98.5 million. The shares will be distributed among 23 recipients, including directors, executive officers without director status, and employees. Under the program, recipients must hold the shares for a restriction period from July 22, 2026, until July 21, 2029. During this period, the shares cannot be transferred, pledged, or otherwise disposed of.
Restrictions will be lifted upon continuous service with the company or its subsidiaries throughout the restriction period. In case of resignation due to retirement or other legitimate reasons, restrictions will be lifted immediately upon departure, subject to certain conditions. Additionally, the company retains the right to acquire the shares free of charge if the restrictions are not lifted at the end of the period. Shares will be managed through a dedicated account at Nomura Securities during the restriction period to ensure compliance with the agreement.
🟢 Confidence: High AI-translated content.